Adequan Canine Injectable 100 mg/mL, 5 mL Vial

• Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. This is more commonly known as osteoarthritis (OA).


• Adequan® Canine (polysulfated glycosaminoglycan) is the only FDA-approved disease-modifying osteoarthritis drug for dogs.


• It proactively treats the disease and not just the signs.


• Adequan® Canine helps to restore joint lubrication, relieve inflammation, and renew the building blocks of healthy joint cartilage
  - to help keep dogs moving.


• Adequan® Canine can be used early, at the first clinical signs of degenerative joint disease (DJD).


• Continue to use it as prescribed by your veterinarian to treat arthritis and help maintain mobility and comfort.


• Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer.

For: Dogs

Brand Name: Adequan Canine

Drug Class: Disease-modifying osteoarthritis drug (DMOAD)

Product Strength & Size: This sterileinjectable solutioncontains 100 mg of polysulfated glycosaminoglycan per 1 mL of solution and is supplied in 5 mL preservedmultiple dose vials. Please ensure the selected product and package size are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above.

Manufacturer: American Regent Animal Health